AUPH — Aurinia Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Aurinia Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	398	466	389	350	358
Net Total Accounts Receivable
Net Total Receivables	1.02	15.4	13.5	24.1	36.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	419	513	443	425	447
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.3	9.8	8.56	117	98.9
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	464	543	471	548	551
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32	40.6	46.1	77.2	97.8
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	55.9	64.3	65.4	170	173
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	408	479	405	378	377
Total Liabilities & Shareholders' Equity	464	543	471	548	551
Total Common Shares Outstanding